日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment patterns and clinical outcomes in chemotherapy-treated patients with HR+/HER2- metastatic breast cancer using real-world data in France and Germany

利用法国和德国的真实世界数据,分析接受化疗的HR+/HER2-转移性乳腺癌患者的治疗模式和临床结果

Campone, Mario; Frenel, Jean-Sebastien; Kiver, Verena I I; Woeckel, Achim; Kerscher, Alexander; Krebs, Markus; Leal, Cátia; Saglimbene, Valeria M; Ann, Quratul; Sadetsky, Natalia; Sjekloca, Nikoleta; Libert, Olivier; Kaushik, Ankita; Bocquet, Francois

Patritumab deruxtecan in HR(+)HER2(-) advanced breast cancer: a phase 2 trial

Patritumab deruxtecan治疗HR(+)HER2(-)晚期乳腺癌:一项II期试验

Pistilli, Barbara; Mosele, Fernanda; Corcos, Noemie; Pierotti, Livia; Pradat, Yoann; Le Bescond, Loic; Lacroix-Triki, Magali; Nachabeh, Ghada; Alfaro, Alexia; Catelain, Cyril; Job, Bastien; Mami-Chouaib, Fathia; Badel, Severine; Farace, Françoise; Oulhen, Marianne; Kannouche, Patricia; Tran, Diep T N; Droin, Nathalie; Vicier, Cecile; Frenel, Jean Sebastien; D'Hondt, Veronique; Dalenc, Florence; Bachelot, Thomas; Ducoulombier, Agnes; Benderra, Marc Antoine; Loirat, Delphine; Mayeur, Didier; Deluche, Elise; Deneuve, Jacqueline; Cheikh-Hussin, Rasha; Guyader, Pierre; Signolle, Nicolas; Godefroy, Karine; Talbot, Hugues; Vakalopoulou, Maria; Christodoulidis, Stergios; Bernard, Elsa; Koudou, Yves; Sporchia, Andrea; Suto, Fumitaka; Li, Lie; Sternberg, David W; Michiels, Stefan; André, Fabrice; Sellami, Dalila; Montagnac, Guillaume

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMT(methylated)/DGKI(methylated) glioblastoma.

选择性破坏 DNMT1/ELK1 相互作用可诱导 DGKI 重新表达,并促进 MGMT(甲基化)/DGKI(甲基化) 胶质母细胞瘤对替莫唑胺的敏感性

Besson Jean-Maxime, Etcheverry Amandine, Nadaradjane Arulraj, Bougras-Cartron Gwenola, Aubry Marc, Frenel Jean-Sebastien, Chevanieu Alain, Lopez Marie, Mosser Jean, Cartron Pierre-François

Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer

在接受曲妥珠单抗-德鲁西替康治疗后,图卡替尼联合治疗ERBB2阳性转移性乳腺癌患者

Frenel, Jean-Sebastien; Zeghondy, Jean; Guérin-Charbonnel, Catherine; Mailliez, Audrey; Volant, Elsa; Poumeaud, François; Patsouris, Anne; Arnedos, Monica; Bailleux, Caroline; Cabal, Julie; Galland, Loick; de Nonneville, Alexandre; Guiu, Séverine; Dalenc, Florence; Pistilli, Barbara; Bachelot, Thomas; Pierga, Jean-Yves; Le Du, Fanny; Bocquet, François; Larrouquere, Louis; Loirat, Delphine

Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database

大型多中心真实世界数据库中转移性乳腺癌患者的生存结局与生殖系BRCA1/2状态的关系

Mailliez, Audrey; D'Hondt, Veronique; Lusque, Amelie; Caron, Olivier; Cabel, Luc; Goncalves, Anthony; Debled, Marc; Gladieff, Laurence; Ferrero, Jean-Marc; Petit, Thierry; Mouret-Reynier, Marie Ange; Eymard, Jean-Christophe; Levy, Christelle; Uwer, Lionel; Leheurteur, Marianne; Desmoulins, Isabelle; Bachelot, Thomas; Frenel, Jean-Sebastien; de la Motte Rouge, Thibault; Simon, Gaëtane; Jacot, William; Delaloge, Suzette

Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results

低分割立体定向再照射联合抗PD-L1药物度伐利尤单抗治疗复发性胶质母细胞瘤:STERIMGLI I期研究结果

Pouessel, Damien; Ken, Soléakhéna; Gouaze-Andersson, Valérie; Piram, Lucie; Mervoyer, Augustin; Larrieu-Ciron, Delphine; Cabarrou, Bastien; Lusque, Amélie; Robert, Marie; Frenel, Jean-Sebastien; Uro-Coste, Emmanuelle; Olivier, Pascale; Mounier, Muriel; Sabatini, Umberto; Sanchez, Eduardo Hugo; Zouitine, Mehdi; Berjaoui, Ahmad; Cohen-Jonathan Moyal, Elizabeth

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis

利用基因组特征指导法国早期乳腺癌患者辅助化疗决策:一项成本效益分析

Curtit, Elsa; Bellanger, Martine Marie; Nerich, Virginie; Hequet, Delphine; Frenel, Jean-Sebastien; Cristeau, Olivier; Rouzier, Roman

The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis

胶质母细胞瘤中 EGFRvIII 转录组:一项元组学分析

Hoogstrate, Youri; Ghisai, Santoesha A; de Wit, Maurice; de Heer, Iris; Draaisma, Kaspar; van Riet, Job; van de Werken, Harmen J G; Bours, Vincent; Buter, Jan; Vanden Bempt, Isabelle; Eoli, Marica; Franceschi, Enrico; Frenel, Jean-Sebastien; Gorlia, Thierry; Hanse, Monique C; Hoeben, Ann; Kerkhof, Melissa; Kros, Johan M; Leenstra, Sieger; Lombardi, Giuseppe; Lukacova, Slávka; Robe, Pierre A; Sepulveda, Juan M; Taal, Walter; Taphoorn, Martin; Vernhout, René M; Walenkamp, Annemiek M E; Watts, Colin; Weller, Michael; de Vos, Filip Y F; Jenster, Guido W; van den Bent, Martin; French, Pim J

Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer

HER2状态对早期三阴性乳腺癌新辅助化疗后病理反应的影响

Domergue, Camille; Martin, Elodie; Lemarié, Camille; Jézéquel, Pascal; Frenel, Jean-Sebastien; Augereau, Paule; Campone, Mario; Patsouris, Anne

The predictive value of patient-reported outcomes on the impact of breast cancer treatment-related quality of life

患者报告结局对乳腺癌治疗相关生活质量影响的预测价值

Zhou, Ke; Bellanger, Martine; Le Lann, Sophie; Robert, Marie; Frenel, Jean-Sebastien; Campone, Mario